Sleep Apnea: Types, Mechanisms, and Clinical Cardiovascular Consequences

Shahrokh Javaheri, Ferran Barbe, Francisco Campos-Rodriguez, Jerome A. Dempsey, Rami Khayat, Sogol Javaheri, Atul Malhotra, Miguel A. Martinez-Garcia, Reena Mehra, Allan I. Pack, Vsevolod Y. Polotsky, Susan Redline, Virend Somers

Research output: Contribution to journalReview article

214 Citations (Scopus)

Abstract

Sleep apnea is highly prevalent in patients with cardiovascular disease. These disordered breathing events are associated with a profile of perturbations that include intermittent hypoxia, oxidative stress, sympathetic activation, and endothelial dysfunction, all of which are critical mediators of cardiovascular disease. Evidence supports a causal association of sleep apnea with the incidence and morbidity of hypertension, coronary heart disease, arrhythmia, heart failure, and stroke. Several discoveries in the pathogenesis, along with developments in the treatment of sleep apnea, have accumulated in recent years. In this review, we discuss the mechanisms of sleep apnea, the evidence that addresses the links between sleep apnea and cardiovascular disease, and research that has addressed the effect of sleep apnea treatment on cardiovascular disease and clinical endpoints. Finally, we review the recent development in sleep apnea treatment options, with special consideration of treating patients with heart disease. Future directions for selective areas are suggested.

Original languageEnglish (US)
Pages (from-to)841-858
Number of pages18
JournalJournal of the American College of Cardiology
Volume69
Issue number7
DOIs
StatePublished - Feb 21 2017

Fingerprint

Sleep Apnea Syndromes
Cardiovascular Diseases
Coronary Disease
Cardiac Arrhythmias
Heart Diseases
Respiration
Oxidative Stress
Therapeutics
Heart Failure
Stroke
Hypertension
Morbidity
Incidence
Research

Keywords

  • central sleep apnea
  • hypertension
  • obstructive sleep apnea

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Sleep Apnea : Types, Mechanisms, and Clinical Cardiovascular Consequences. / Javaheri, Shahrokh; Barbe, Ferran; Campos-Rodriguez, Francisco; Dempsey, Jerome A.; Khayat, Rami; Javaheri, Sogol; Malhotra, Atul; Martinez-Garcia, Miguel A.; Mehra, Reena; Pack, Allan I.; Polotsky, Vsevolod Y.; Redline, Susan; Somers, Virend.

In: Journal of the American College of Cardiology, Vol. 69, No. 7, 21.02.2017, p. 841-858.

Research output: Contribution to journalReview article

Javaheri, S, Barbe, F, Campos-Rodriguez, F, Dempsey, JA, Khayat, R, Javaheri, S, Malhotra, A, Martinez-Garcia, MA, Mehra, R, Pack, AI, Polotsky, VY, Redline, S & Somers, V 2017, 'Sleep Apnea: Types, Mechanisms, and Clinical Cardiovascular Consequences', Journal of the American College of Cardiology, vol. 69, no. 7, pp. 841-858. https://doi.org/10.1016/j.jacc.2016.11.069
Javaheri S, Barbe F, Campos-Rodriguez F, Dempsey JA, Khayat R, Javaheri S et al. Sleep Apnea: Types, Mechanisms, and Clinical Cardiovascular Consequences. Journal of the American College of Cardiology. 2017 Feb 21;69(7):841-858. https://doi.org/10.1016/j.jacc.2016.11.069
Javaheri, Shahrokh ; Barbe, Ferran ; Campos-Rodriguez, Francisco ; Dempsey, Jerome A. ; Khayat, Rami ; Javaheri, Sogol ; Malhotra, Atul ; Martinez-Garcia, Miguel A. ; Mehra, Reena ; Pack, Allan I. ; Polotsky, Vsevolod Y. ; Redline, Susan ; Somers, Virend. / Sleep Apnea : Types, Mechanisms, and Clinical Cardiovascular Consequences. In: Journal of the American College of Cardiology. 2017 ; Vol. 69, No. 7. pp. 841-858.
@article{f87a74b53a75409baf5b715627fc1f9c,
title = "Sleep Apnea: Types, Mechanisms, and Clinical Cardiovascular Consequences",
abstract = "Sleep apnea is highly prevalent in patients with cardiovascular disease. These disordered breathing events are associated with a profile of perturbations that include intermittent hypoxia, oxidative stress, sympathetic activation, and endothelial dysfunction, all of which are critical mediators of cardiovascular disease. Evidence supports a causal association of sleep apnea with the incidence and morbidity of hypertension, coronary heart disease, arrhythmia, heart failure, and stroke. Several discoveries in the pathogenesis, along with developments in the treatment of sleep apnea, have accumulated in recent years. In this review, we discuss the mechanisms of sleep apnea, the evidence that addresses the links between sleep apnea and cardiovascular disease, and research that has addressed the effect of sleep apnea treatment on cardiovascular disease and clinical endpoints. Finally, we review the recent development in sleep apnea treatment options, with special consideration of treating patients with heart disease. Future directions for selective areas are suggested.",
keywords = "central sleep apnea, hypertension, obstructive sleep apnea",
author = "Shahrokh Javaheri and Ferran Barbe and Francisco Campos-Rodriguez and Dempsey, {Jerome A.} and Rami Khayat and Sogol Javaheri and Atul Malhotra and Martinez-Garcia, {Miguel A.} and Reena Mehra and Pack, {Allan I.} and Polotsky, {Vsevolod Y.} and Susan Redline and Virend Somers",
year = "2017",
month = "2",
day = "21",
doi = "10.1016/j.jacc.2016.11.069",
language = "English (US)",
volume = "69",
pages = "841--858",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "7",

}

TY - JOUR

T1 - Sleep Apnea

T2 - Types, Mechanisms, and Clinical Cardiovascular Consequences

AU - Javaheri, Shahrokh

AU - Barbe, Ferran

AU - Campos-Rodriguez, Francisco

AU - Dempsey, Jerome A.

AU - Khayat, Rami

AU - Javaheri, Sogol

AU - Malhotra, Atul

AU - Martinez-Garcia, Miguel A.

AU - Mehra, Reena

AU - Pack, Allan I.

AU - Polotsky, Vsevolod Y.

AU - Redline, Susan

AU - Somers, Virend

PY - 2017/2/21

Y1 - 2017/2/21

N2 - Sleep apnea is highly prevalent in patients with cardiovascular disease. These disordered breathing events are associated with a profile of perturbations that include intermittent hypoxia, oxidative stress, sympathetic activation, and endothelial dysfunction, all of which are critical mediators of cardiovascular disease. Evidence supports a causal association of sleep apnea with the incidence and morbidity of hypertension, coronary heart disease, arrhythmia, heart failure, and stroke. Several discoveries in the pathogenesis, along with developments in the treatment of sleep apnea, have accumulated in recent years. In this review, we discuss the mechanisms of sleep apnea, the evidence that addresses the links between sleep apnea and cardiovascular disease, and research that has addressed the effect of sleep apnea treatment on cardiovascular disease and clinical endpoints. Finally, we review the recent development in sleep apnea treatment options, with special consideration of treating patients with heart disease. Future directions for selective areas are suggested.

AB - Sleep apnea is highly prevalent in patients with cardiovascular disease. These disordered breathing events are associated with a profile of perturbations that include intermittent hypoxia, oxidative stress, sympathetic activation, and endothelial dysfunction, all of which are critical mediators of cardiovascular disease. Evidence supports a causal association of sleep apnea with the incidence and morbidity of hypertension, coronary heart disease, arrhythmia, heart failure, and stroke. Several discoveries in the pathogenesis, along with developments in the treatment of sleep apnea, have accumulated in recent years. In this review, we discuss the mechanisms of sleep apnea, the evidence that addresses the links between sleep apnea and cardiovascular disease, and research that has addressed the effect of sleep apnea treatment on cardiovascular disease and clinical endpoints. Finally, we review the recent development in sleep apnea treatment options, with special consideration of treating patients with heart disease. Future directions for selective areas are suggested.

KW - central sleep apnea

KW - hypertension

KW - obstructive sleep apnea

UR - http://www.scopus.com/inward/record.url?scp=85012952342&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85012952342&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2016.11.069

DO - 10.1016/j.jacc.2016.11.069

M3 - Review article

C2 - 28209226

AN - SCOPUS:85012952342

VL - 69

SP - 841

EP - 858

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 7

ER -